Subjective Patient Assessment Comparing Overall Tolerability and Satisfaction of a Prostaglandin Analogue Including Either Bimatoprost 0.01% or Latanoprost.
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2014
At a glance
- Drugs Bimatoprost (Primary) ; Latanoprost
- Indications Glaucoma
- Focus Adverse reactions
- 24 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Jul 2014 New trial record